Four-dimensional neuronal signaling by nitric oxide: a computational analysis.

Nitric oxide (NO) is now recognized as a transmitter of neurons that express the neuronal isoform of the enzyme nitric oxide synthase. NO, however, violates some of the key tenets of chemical transmission, which is classically regarded as occurring at points of close apposition between neurons. It is the ability of NO to diffuse isotropically in aqueous and lipid environments that has suggested a radically different form of signaling in which the transmitter acts four-dimensionally in space and time, affecting volumes of the brain containing many neurons and synapses. Although "volume signaling" clearly challenges simple connectionist models of neural processing, crucial to its understanding are the spatial and temporal dynamics of the spread of NO within the brain. Existing models of NO diffusion, however, have serious shortcomings because they represent solutions for "point-sources," which have no physical dimensions. Methods for overcoming these difficulties are presented here, and results are described that show how NO spreads from realistic neural architectures with both simple symmetrical and irregular shapes. By highlighting the important influence of the geometry of NO sources, our results provide insights into the four-dimensional spread of a diffusing messenger. We show for example that reservoirs of NO that accumulate in volumes of the nervous system where NO is not synthesized contribute significantly to the temporal and spatial dynamics of NO spread.

The afterdepolarization in Rana temporaria muscle fibres following osmotic shock.

Rana temporaria sartorius muscle fibres were exposed to varied sequences of solution and temperature changes that have been employed hitherto in procedures that sought to decouple the transverse tubules from the surface membrane. The incidence of such detubulation was assessed in large numbers of fibres through demonstrating a loss or otherwise of the after-depolarization that normally reflects successful tubular propagation of the surface action potential. This criterion yielded assessments of the existing detubulation techniques in agreement with earlier results. The experiments then developed an improved detubulation procedure that required only brief (15 min) exposures to glycerol, its replacement in a single step by a Ca2+/Mg(2+)-Ringer solution for 30 min, and rapid cooling from room temperature (19-21 degrees C) to 6-10 degrees C prior to final restoration of the normal Ringer solution. This sequence of steps yielded an optimal incidence (98%) of detubulation in viable surface fibres that were amenable to electrophysiological studies. Studies that systematically modified the detubulation procedure demonstrated that the omission of any one step in the protocol significantly reduced the incidence of detubulation with or without accompanying deteriorations in fibre resting potentials. Successful detubulation accordingly required an initial exposure to an optimal glycerol concentration that lasted for a minimal duration and for its abrupt withdrawal. Inclusion of a cooling step within 30 min after glycerol withdrawal was coincident with, and critical to, optimal tubular isolation. Thus, cooling steps that either preceded, or that followed the glycerol withdrawal step by more than 60 min, resulted in a sharp reduction in the incidence of detubulation. Similarly, a critical period of exposure to Ca2+/Mg2+ Ringer solution also promoted detubulation without compromising the recovery of stable and satisfactory resting potentials. The findings reported here remain consistent with a primarily osmotic mechanism for detubulation. However, they demonstrated additional and important influences of temperature and of divalent cation concentration on the extent of tubular detachment when such factors were modified during the time course of the expected volume changes that followed each adjustment in osmotic condition.

Extension of the mitochondrial transporter super-family: sequences of five members from the nematode worm, Caenorhabditis elegans.

The sequences are presented of cDNAs encoding five related proteins from the nematode worm, Caenorhabditis elegans. Three of them can be recognised as the homologues of the ADP/ATP, phosphate and oxoglutarate/malate carrier proteins that have been found in the inner membranes of mitochondria in other species. These carrier proteins, and the uncoupling protein from the mitochondria in mammalian brown adipose tissue, have common features in their primary and secondary structures, and are members of the same protein super-family. Members of this super-family have polypeptide chains approximately 300 amino acid long that consist of three tandem related sequences of about 100 amino acids. The tandem repeats from the different proteins are inter-related, and each repeat is probably folded into a common secondary structural motif consisting of two hydrophobic stretches of amino acids with the potential to form membrane spanning alpha-helices, linked by an extensive hydrophilic region. The common characteristic features of this family of proteins are also present in sequences of two further proteins, named C1 and C2, encoded in nematode cDNAs, and in four published protein sequences from various sources. Neither the transport properties nor the subcellular locations of any of this latter group of six proteins are known. Therefore, currently the super-family of mitochondrial carrier proteins has at least ten different members.

The metabolism of 2,5-diphenyloxazole (PPO) in human lymphocytes and rat liver microsomes.

The oxidative metabolism of 2,5-diphenyloxazole (PPO) is associated with 3-methylcholanthrene inducible cytochrome P-450. The major metabolite formed has m/z of 237, corresponding to hydroxylated PPO. All the possible hydroxylated metabolites of PPO were synthesized and characterized, enabling the assignment of a structure for the major metabolite and two minor metabolites. The metabolites are easily extracted and their fluorescence is quantifiable in alkaline medium with a sample fluorescence to blank fluorescence ratio of 400:1. A sensitive HPLC assay of PPO metabolism was also developed. PPO metabolism is readily catalyzed by 3-methylcholanthrene-induced rat liver microsomes and strongly inhibited by alpha-naphthoflavone, but poorly inhibited by metyrapone or SKF 525A, indicating the involvement of cytochrome P-448 or P1-450 in the metabolism of PPO. With human lymphocytes the method has proven to be a good indicator of "aryl hydrocarbon hydroxylase" (AHH) activity, correlating well with AHH assays using benzo(alpha)pyrene (BP) as a substrate. Both the induced BP and PPO metabolism by human lymphocytes is inhibited by alpha-naphthoflavone, but not by metyrapone.

Identification and synthesis of O-methylcatechol metabolites of phenobarbital and some N-alkyl derivatives.

5-Ethyl-5-(4-hydroxy-3-methoxyphenyl) barbituric acid was identified as a new, minor metabolite of phenobarbital in man. The identity of this O-methylcatechol metabolite was confirmed by an unequivocal chemical synthesis, and by GC-MS studies. Mephobarbital and the 1,3-dimethyl, 1-ethyl, and 1,3-diethyl analogues of phenobarbital yielded the corresponding N-alkylated O-methylcatechol metabolites, all of which were confirmed by synthesis. The N-alkyl barbiturates each gave additionally at least one O-methylcatechol metabolite in which N-dealkylation had occurred. These metabolites accounted for approximately 1-5% of the orally administered dose in man.